Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277641 · ClinicalTrials.gov registry record · Phase 3
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
A Phase 3 study, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 3
- Development phase
- 70
- Enrollment target
NCT00277641 is a Phase 3 study that has completed, run by Lindner Center of HOPE. The registered enrollment target is 70 participants.
The verdict
NCT00277641, a Phase 3 study, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 70 participants
- Enrollment target
Study Summary
This research study is to evaluate the effectiveness, tolerability, and safety of lamotrigine therapy in the treatment of binge eating disorder associated with obesity. Lamotrigine has been approved by the Food and Drug Administration for the treatment of bipolar disorder, but has not been approved for use in the treatment of binge eating disorder with obesity.
Interventions
- DRUG placebo
- DRUG Lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00277641
The ClinicalTrials.gov registry entry for NCT00277641 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindner Center of HOPE, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00277641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00277641 about?
NCT00277641 is a clinical study titled "Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity". This research study is to evaluate the effectiveness, tolerability, and safety of lamotrigine therapy in the treatment of binge eating disorder associated with obesity. Lamotrigine has been approved by the Food and Drug Administration for the treatment of bipolar disorder, but has not been approved...
What is the current status of trial NCT00277641?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 70 participants. The study started on 2006-03. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00277641?
The interventions under investigation include: placebo (DRUG), Lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00277641?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.